# Unanchored K63-linked polyubiquitin chains: a novel second messenger involved in G protein-coupled receptors early signaling events

**Authors:** Priscilla Doyon, Daniel El-Mortada, Jiunn Roy, Firas El-Mortada, Florence Dô, Simon-Pierre Gravel, Marc J. Servant

PMC · DOI: 10.1186/s12964-025-02646-6 · 2026-01-08

## TL;DR

This study shows that unanchored K63-linked polyubiquitin chains act as second messengers in GPCR signaling, influencing early inflammatory responses.

## Contribution

The paper introduces unanchored K63-linked polyubiquitin chains as novel second messengers in GPCR signaling pathways.

## Key findings

- Unanchored K63-linked polyubiquitin chains are produced transiently during GPCR activation.
- These chains are TRAF6-dependent and accumulate in TAK1 and IKKβ immunocomplexes.
- Binding of ZnF-UBP reduces T-loop phosphorylation and affects early transcriptional events.

## Abstract

G protein-coupled receptors (GPCRs) rapidly transmit extracellular signals by activating effector proteins, thereby producing well-characterized second messenger molecules. Free, unanchored polyubiquitin chains have been proposed as secondary messengers in immune and inflammatory pathways that regulate cellular responses to invading pathogens and the inflammatory cytokine Interleukin-1 beta (IL-1β). It remains unknown whether these molecules play a role in GPCR signaling. The present study used primary, immortalized, and transformed cellular models, together with loss-of-function approaches, to demonstrate the presence and functions of unanchored polyubiquitin chains in inflammatory signaling pathways that activate the activator protein 1 (AP-1) and nuclear factor-kappa B (NF-κB) transcription factors.

In response to inflammatory GPCR agonists Angiotensin II (Ang II), lysophosphatidic acid (LPA), and thrombin (Thr), the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6) controls early signaling events that lead to T-loop phosphorylation of Transforming Growth Factor β-activated kinase 1 (TAK1), IκB kinase beta (IKKβ), c-Jun N-terminal kinases (JNK1/2), and p38 mitogen-activated protein kinases (p38). In parallel, we document the rapid, transient TRAF6-dependent production of unanchored lysine (K)63-linked polyubiquitin chains that accumulate in TAK1 and IKKβ immunocomplexes. Pull-down assays specifically designed to capture unanchored polyubiquitin chains in cellular extracts from stimulated cells further support their transient nature. Lastly, stable expression of a zinc finger ubiquitin-binding protein (ZnF-UBP) domain, which specifically binds unanchored polyubiquitin chains in immortalized keratinocytes exposed to LPA and Thr, shows that this production occurs in the proximity to the plasma membrane and diminishes the T-loop phosphorylation of TAK1, IKKβ, JNK1/2, and p38, thereby affecting the induction of early transcriptional events.

Our results support a novel paradigm in GPCR signal transduction, identifying unanchored K63-linked polyubiquitin chains as second messenger molecules.

The online version contains supplementary material available at 10.1186/s12964-025-02646-6.

## Linked entities

- **Genes:** TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189], MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885], IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551], CRK (CRK proto-oncogene, adaptor protein) [NCBI Gene 1398]
- **Proteins:** FOS (Fos proto-oncogene, AP-1 transcription factor subunit), NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** Angiotensin II (PubChem CID 65143), lysophosphatidic acid (PubChem CID 5497152)

## Full-text entities

- **Genes:** Il1b (interleukin 1 beta) [NCBI Gene 24494] {aka IL-1F2}, IKBKG (inhibitor of nuclear factor kappa B kinase regulatory subunit gamma) [NCBI Gene 8517] {aka AMCBX1, EDAID1, FIP-3, FIP3, Fip3p, IKK-gamma}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, USP5 (ubiquitin specific peptidase 5) [NCBI Gene 8078] {aka ISOT}, PIN4 (peptidylprolyl cis/trans isomerase, NIMA-interacting 4) [NCBI Gene 5303] {aka EPVH, PAR14, PAR17, hEPVH, hPar14, hPar17}, BCL10 (BCL10 immune signaling adaptor) [NCBI Gene 8915] {aka CARMEN, CIPER, CLAP, IMD37, c-E10, mE10}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, Ikbkb (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 84351] {aka AIM-1, IKK2}, FOSL1 (FOS like 1, AP-1 transcription factor subunit) [NCBI Gene 8061] {aka FRA, FRA1, fra-1}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, CREB1 (cAMP responsive element binding protein 1) [NCBI Gene 1385] {aka CREB, CREB-1}, MAP3K5 (mitogen-activated protein kinase kinase kinase 5) [NCBI Gene 4217] {aka ASK1, MAPKKK5, MEKK5}, ATF3 (activating transcription factor 3) [NCBI Gene 467], HPRT1 (hypoxanthine phosphoribosyltransferase 1) [NCBI Gene 3251] {aka HGPRT, HPRT}, ZNF629 (zinc finger protein 629) [NCBI Gene 23361] {aka ZNF, ZNF65}, LPAR3 (lysophosphatidic acid receptor 3) [NCBI Gene 23566] {aka EDG7, Edg-7, GPCR, HOFNH30, LP-A3, LPA3}, TAB3 (TGF-beta activated kinase 1 (MAP3K7) binding protein 3) [NCBI Gene 257397] {aka MAP3K7IP3, NAP1}, Mapk14 (mitogen activated protein kinase 14) [NCBI Gene 81649] {aka CRK1, CSBP, CSPB1, Csbp1, Csbp2, Exip}, TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1) [NCBI Gene 10454] {aka 3'-Tab1, MAP3K7IP1}, Usp5 (ubiquitin specific peptidase 5) [NCBI Gene 297593], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CBLL2 (Cbl proto-oncogene like 2) [NCBI Gene 158506] {aka CT138, HAKAIL, ZNF645}, MALT1 (MALT1 paracaspase) [NCBI Gene 10892] {aka IMD12, MLT, MLT1, PCASP1}, SUCLG1 (succinate-CoA ligase GDP/ADP-forming subunit alpha) [NCBI Gene 8802] {aka GALPHA, MTDPS9, SUCLA1}, Traf6 (TNF receptor associated factor 6) [NCBI Gene 311245], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, Agt (angiotensinogen) [NCBI Gene 24179] {aka ANRT, Ang, AngII, PAT}, PRRT2 (proline rich transmembrane protein 2) [NCBI Gene 112476] {aka BFIC2, BFIS2, DSPB3, DYT10, EKD1, FICCA}, DUSP5 (dual specificity phosphatase 5) [NCBI Gene 1847] {aka DUSP, HVH3}, PRKCA (protein kinase C alpha) [NCBI Gene 5578] {aka AAG6, PKC-alpha, PKCA, PKCI+/-, PKCalpha}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, UBD (ubiquitin like modifier D) [NCBI Gene 10537] {aka FAT10, UBD-3}, HSPG2 (heparan sulfate proteoglycan 2) [NCBI Gene 3339] {aka HSPG, PLC, PRCAN, SJA, SJS, SJS1}, NEDD4L (NEDD4 like E3 ubiquitin protein ligase) [NCBI Gene 23327] {aka NEDD4-2, NEDD4.2, PVNH7, RSP5, hNEDD4-2}, ELK1 (ETS transcription factor ELK1) [NCBI Gene 2002], NCF1 (neutrophil cytosolic factor 1) [NCBI Gene 653361] {aka CGD1, NCF-1, NCF-47K, NCF1A, NOXO2, SH3PXD1A}, USP1 (ubiquitin specific peptidase 1) [NCBI Gene 7398] {aka UBP}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CARD10 (caspase recruitment domain family member 10) [NCBI Gene 29775] {aka BIMP1, CARMA3, IMD89}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, TUBA4A (tubulin alpha 4a) [NCBI Gene 7277] {aka ALS22, CMYO26, FTDALS9, H2-ALPHA, OZEMA23, SPAX11}, MAP3K3 (mitogen-activated protein kinase kinase kinase 3) [NCBI Gene 4215] {aka CCM5, MAPKKK3, MEKK3}, TRAF6 (TNF receptor associated factor 6) [NCBI Gene 7189] {aka MGC:3310, RNF85}, SUCLG2 (succinate-CoA ligase GDP-forming subunit beta) [NCBI Gene 8801] {aka G-SCS, GBETA, GTPSCS}, TNFAIP3 (TNF alpha induced protein 3) [NCBI Gene 7128] {aka A20, AIFBL1, AISBL, OTUD7C, TNFA1P2}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, Map3k7 (mitogen activated protein kinase kinase kinase 7) [NCBI Gene 313121] {aka Tak1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TAB2 (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) [NCBI Gene 23118] {aka CHTD2, MAP3K7IP2, TAB-2}, MAPK9 (mitogen-activated protein kinase 9) [NCBI Gene 5601] {aka JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, CDK9 (cyclin dependent kinase 9) [NCBI Gene 1025] {aka C-2k, CDC2L4, CTK1, PITALRE, TAK}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}
- **Diseases:** inflammatory (MESH:D007249)
- **Chemicals:** methanol (MESH:D000432), penicillin (MESH:D010406), pepstatin A (MESH:C031375), DAG (MESH:D004075), NaF (MESH:D012969), amino acids (MESH:D000596), glutathione (MESH:D005978), phospholipid (MESH:D010743), glycine (MESH:D005998), PA (MESH:D010712), DTT (MESH:D004229), NaCl (MESH:D012965), puromycin (MESH:D011691), 5Z-7-oxozeaenol (MESH:C505734), HCl (MESH:D006851), N-Ethylmaleimide (MESH:D005033), CO2 (MESH:D002245), cyclic adenosine monophosphate (MESH:D000242), cGMP (MESH:D006152), beta-glycerophosphate (MESH:C031463), Triton X-100 (MESH:D017830), acrylamide (MESH:D020106), Lipofectamine (MESH:C086724), KCl (MESH:D011189), calcium (MESH:D002118), streptomycin (MESH:D013307), sodium deoxycholate (MESH:D003840), PBS (-), poly-A (MESH:D011061), polybrene (MESH:D006583), Sepharose (MESH:D012685), glycerol (MESH:D005990), EDTA (MESH:D004492), PMA (MESH:D013755), HEPES (MESH:D006531), SDS (MESH:D012967), MgCl2 (MESH:D015636), DAPI (MESH:C007293), PFA (MESH:C003043), leupeptin (MESH:C032854), pefabloc (MESH:C002010), poly-glycine (MESH:C011080), Lysophosphatidic acid (MESH:C032881), IP3 (MESH:D015544)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mycoplasma (genus) [taxon 2093], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** R221K, R222W, Y223F, A301-827A
- **Cell lines:** BL21 — Homo sapiens (Human), EBV-related Burkitt lymphoma, Cancer cell line (CVCL_M639), -E — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z894), E VSMC — Homo sapiens (Human), Finite cell line (CVCL_4009), CRL-11268 — Homo sapiens (Human), Frontotemporal dementia, Transformed cell line (CVCL_HR73), Plat-A — Homo sapiens (Human), Transformed cell line (CVCL_B489), E1ARasV12 — Mus musculus (Mouse), Hybridoma (CVCL_A8EQ), 293 T — Homo sapiens (Human), Transformed cell line (CVCL_0063), Ham's F-12 — Mesocricetus auratus (Golden hamster), Hamster cholangiocarcinoma, Cancer cell line (CVCL_B1CT), MEFs — Mus musculus (Mouse), Finite cell line (CVCL_9115), HaCaT — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0038)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12983627/full.md

---
Source: https://tomesphere.com/paper/PMC12983627